Davide Binda

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Guido Cavaletti, David R. Cornblath, Ingemar S. J. Merkies et al. · Annals of Oncology · 2012 · 284 citations · Full text

Health Sciences, Peripheral Nerve Injury, Pain Medicine +10

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

Paola Alberti, Emanuela Rossi, David R. Cornblath et al. · Annals of Oncology · 2013 · 171 citations · Full text

Neurotoxicology, Pharmacology, Neuropathic Pain +4

Current treatment practice of Guillain-Barré syndrome

Christine Verboon, Alex Y. Doets, Giuliana Galassi et al. · Neurology · 2019 · 87 citations · Full text

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)

Davide Binda, Els K. Vanhoutte, Guido Cavaletti et al. · European Journal of Cancer · 2013 · 46 citations

Neurorehabilitation, Neuro-oncology, Peripheral Nerve Injury +8

Rasch‐Transformed Total Neuropathy Score clinical version (RT‐TNSc^©) in patients with chemotherapy‐induced peripheral neuropathy

Davide Binda, Guido Cavaletti, David R. Cornblath et al. · Journal of the Peripheral Nervous System · 2015 · 25 citations

Acceptable Model Fit, Peripheral Nerve Injury, Clinical Neurology +21